Table 2. PTBP2 expression and clinicopathological parameters in human CRC tissues.
| |
|
PTBP2 expression |
|
|
|---|---|---|---|---|
| Parameters | Cases | Negative | Positive | P value |
|
Sex | ||||
| Male | 25 | 5 | 20 | 0.3214 |
| Female |
35 |
6 |
29 |
|
|
Age (years) | ||||
| <60 | 31 | 7 | 24 | 0.0876 |
| ⩾60 |
29 |
4 |
25 |
|
|
Tumour size (diameter,
d cm−1) | ||||
| d<6 | 41 | 8 | 33 | 0.2208 |
|
d⩾6 |
19 |
3 |
16 |
|
|
Histological grade | ||||
| Poor | 23 | 3 | 20 | 0.0929 |
| Moderate and well |
37 |
8 |
29 |
|
|
Invasion and metastasis | ||||
| Present | 39 | 4 | 35 | 0.0377a |
| Absent |
21 |
7 |
14 |
|
|
Duke's stage | ||||
| A–B | 36 | 8 | 28 | 0.0817 |
| C–D | 24 | 3 | 21 | |
Abbreviations: CRC=colorectal cancer; PTBP2=polypyrimidine-tract-binding protein 2.
a
P<0.05 vs no invasion and metastasis group.